nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0746	0.132	CbGbCtD
Nortriptyline—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0674	0.119	CbGbCtD
Nortriptyline—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.054	0.0955	CbGbCtD
Nortriptyline—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0472	0.0836	CbGbCtD
Nortriptyline—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0452	0.08	CbGbCtD
Nortriptyline—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0431	0.0764	CbGbCtD
Nortriptyline—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0365	0.0646	CbGbCtD
Nortriptyline—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0309	0.0548	CbGbCtD
Nortriptyline—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0284	0.0502	CbGbCtD
Nortriptyline—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0283	0.05	CbGbCtD
Nortriptyline—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0263	0.0465	CbGbCtD
Nortriptyline—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0211	0.0374	CbGbCtD
Nortriptyline—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0194	0.0343	CbGbCtD
Nortriptyline—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0121	0.0214	CbGbCtD
Nortriptyline—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0119	0.021	CbGbCtD
Nortriptyline—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0111	0.0196	CbGbCtD
Nortriptyline—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00754	0.0134	CbGbCtD
Nortriptyline—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00671	0.173	CbGeAlD
Nortriptyline—HTR6—ganglion—peripheral nervous system neoplasm	0.00305	0.0787	CbGeAlD
Nortriptyline—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00245	0.0632	CbGeAlD
Nortriptyline—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00229	0.0592	CbGeAlD
Nortriptyline—Amitriptyline—NTRK2—peripheral nervous system neoplasm	0.00216	0.317	CrCbGaD
Nortriptyline—HTR2C—ganglion—peripheral nervous system neoplasm	0.00176	0.0455	CbGeAlD
Nortriptyline—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00175	0.0451	CbGeAlD
Nortriptyline—HTR2A—pons—peripheral nervous system neoplasm	0.00173	0.0445	CbGeAlD
Nortriptyline—SLC6A4—ganglion—peripheral nervous system neoplasm	0.00167	0.0431	CbGeAlD
Nortriptyline—SLC6A2—nerve—peripheral nervous system neoplasm	0.00149	0.0384	CbGeAlD
Nortriptyline—HTR1A—ganglion—peripheral nervous system neoplasm	0.00148	0.0383	CbGeAlD
Nortriptyline—SLC6A2—ganglion—peripheral nervous system neoplasm	0.00147	0.038	CbGeAlD
Nortriptyline—DRD2—nerve—peripheral nervous system neoplasm	0.00136	0.035	CbGeAlD
Nortriptyline—DRD2—ganglion—peripheral nervous system neoplasm	0.00134	0.0346	CbGeAlD
Nortriptyline—Amitriptyline—NTRK1—peripheral nervous system neoplasm	0.00133	0.196	CrCbGaD
Nortriptyline—PTGS1—ganglion—peripheral nervous system neoplasm	0.000981	0.0253	CbGeAlD
Nortriptyline—HTR2A—nerve—peripheral nervous system neoplasm	0.000896	0.0231	CbGeAlD
Nortriptyline—HTR2A—ganglion—peripheral nervous system neoplasm	0.000885	0.0228	CbGeAlD
Nortriptyline—CHRM1—parotid gland—peripheral nervous system neoplasm	0.000772	0.0199	CbGeAlD
Nortriptyline—HTR2C—brainstem—peripheral nervous system neoplasm	0.000767	0.0198	CbGeAlD
Nortriptyline—SLC6A4—brainstem—peripheral nervous system neoplasm	0.000727	0.0187	CbGeAlD
Nortriptyline—Protriptyline—ABCB1—peripheral nervous system neoplasm	0.000703	0.103	CrCbGaD
Nortriptyline—HTR1A—brainstem—peripheral nervous system neoplasm	0.000645	0.0166	CbGeAlD
Nortriptyline—SLC6A2—brainstem—peripheral nervous system neoplasm	0.00064	0.0165	CbGeAlD
Nortriptyline—ADRA1A—brainstem—peripheral nervous system neoplasm	0.000595	0.0153	CbGeAlD
Nortriptyline—DRD2—brainstem—peripheral nervous system neoplasm	0.000583	0.015	CbGeAlD
Nortriptyline—Epinastine—ABCB1—peripheral nervous system neoplasm	0.000521	0.0765	CrCbGaD
Nortriptyline—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.00052	0.0134	CbGeAlD
Nortriptyline—Maprotiline—ABCB1—peripheral nervous system neoplasm	0.000448	0.0659	CrCbGaD
Nortriptyline—HTR2A—brainstem—peripheral nervous system neoplasm	0.000385	0.00992	CbGeAlD
Nortriptyline—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000363	0.00111	CcSEcCtD
Nortriptyline—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.0011	CcSEcCtD
Nortriptyline—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000361	0.0011	CcSEcCtD
Nortriptyline—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000361	0.0011	CcSEcCtD
Nortriptyline—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00036	0.0011	CcSEcCtD
Nortriptyline—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.00109	CcSEcCtD
Nortriptyline—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000358	0.00109	CcSEcCtD
Nortriptyline—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000358	0.00109	CcSEcCtD
Nortriptyline—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000357	0.00109	CcSEcCtD
Nortriptyline—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000357	0.00109	CcSEcCtD
Nortriptyline—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000355	0.00108	CcSEcCtD
Nortriptyline—Malaise—Etoposide—peripheral nervous system neoplasm	0.000354	0.00108	CcSEcCtD
Nortriptyline—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000354	0.00108	CcSEcCtD
Nortriptyline—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000351	0.00107	CcSEcCtD
Nortriptyline—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000351	0.00107	CcSEcCtD
Nortriptyline—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.00107	CcSEcCtD
Nortriptyline—CYP2D6—brainstem—peripheral nervous system neoplasm	0.00035	0.00903	CbGeAlD
Nortriptyline—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00035	0.00107	CcSEcCtD
Nortriptyline—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00035	0.00107	CcSEcCtD
Nortriptyline—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000349	0.00107	CcSEcCtD
Nortriptyline—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000347	0.00106	CcSEcCtD
Nortriptyline—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000345	0.00105	CcSEcCtD
Nortriptyline—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.00105	CcSEcCtD
Nortriptyline—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000344	0.00105	CcSEcCtD
Nortriptyline—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000344	0.00105	CcSEcCtD
Nortriptyline—Rash—Topotecan—peripheral nervous system neoplasm	0.000344	0.00105	CcSEcCtD
Nortriptyline—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000344	0.00105	CcSEcCtD
Nortriptyline—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000344	0.00105	CcSEcCtD
Nortriptyline—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000343	0.00105	CcSEcCtD
Nortriptyline—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000342	0.00105	CcSEcCtD
Nortriptyline—Headache—Topotecan—peripheral nervous system neoplasm	0.000342	0.00104	CcSEcCtD
Nortriptyline—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000341	0.00104	CcSEcCtD
Nortriptyline—Rash—Tretinoin—peripheral nervous system neoplasm	0.000341	0.00104	CcSEcCtD
Nortriptyline—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000341	0.00104	CcSEcCtD
Nortriptyline—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000341	0.00104	CcSEcCtD
Nortriptyline—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000341	0.00104	CcSEcCtD
Nortriptyline—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000341	0.00104	CcSEcCtD
Nortriptyline—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00034	0.00104	CcSEcCtD
Nortriptyline—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00034	0.00104	CcSEcCtD
Nortriptyline—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000339	0.00104	CcSEcCtD
Nortriptyline—Headache—Tretinoin—peripheral nervous system neoplasm	0.000339	0.00104	CcSEcCtD
Nortriptyline—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000339	0.00103	CcSEcCtD
Nortriptyline—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000338	0.00103	CcSEcCtD
Nortriptyline—Constipation—Vincristine—peripheral nervous system neoplasm	0.000338	0.00103	CcSEcCtD
Nortriptyline—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000338	0.00103	CcSEcCtD
Nortriptyline—Rash—Melphalan—peripheral nervous system neoplasm	0.000337	0.00103	CcSEcCtD
Nortriptyline—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000336	0.00103	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000333	0.00102	CcSEcCtD
Nortriptyline—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000333	0.00102	CcSEcCtD
Nortriptyline—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00033	0.00101	CcSEcCtD
Nortriptyline—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000327	0.000997	CcSEcCtD
Nortriptyline—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000326	0.000996	CcSEcCtD
Nortriptyline—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000326	0.000995	CcSEcCtD
Nortriptyline—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000324	0.00099	CcSEcCtD
Nortriptyline—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000324	0.00099	CcSEcCtD
Nortriptyline—Nausea—Topotecan—peripheral nervous system neoplasm	0.000324	0.00099	CcSEcCtD
Nortriptyline—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000323	0.000986	CcSEcCtD
Nortriptyline—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000321	0.000982	CcSEcCtD
Nortriptyline—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000321	0.000982	CcSEcCtD
Nortriptyline—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000318	0.0082	CbGeAlD
Nortriptyline—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.00097	CcSEcCtD
Nortriptyline—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000317	0.000969	CcSEcCtD
Nortriptyline—Nausea—Melphalan—peripheral nervous system neoplasm	0.000317	0.000969	CcSEcCtD
Nortriptyline—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000314	0.000959	CcSEcCtD
Nortriptyline—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000313	0.000958	CcSEcCtD
Nortriptyline—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000312	0.000954	CcSEcCtD
Nortriptyline—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000954	CcSEcCtD
Nortriptyline—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000312	0.000954	CcSEcCtD
Nortriptyline—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000312	0.000954	CcSEcCtD
Nortriptyline—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000309	0.000945	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000943	CcSEcCtD
Nortriptyline—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000305	0.000932	CcSEcCtD
Nortriptyline—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000304	0.000928	CcSEcCtD
Nortriptyline—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000303	0.000925	CcSEcCtD
Nortriptyline—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000302	0.000923	CcSEcCtD
Nortriptyline—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000915	CcSEcCtD
Nortriptyline—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000299	0.000914	CcSEcCtD
Nortriptyline—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000294	0.000899	CcSEcCtD
Nortriptyline—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000293	0.00756	CbGeAlD
Nortriptyline—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000891	CcSEcCtD
Nortriptyline—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000291	0.000889	CcSEcCtD
Nortriptyline—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00029	0.000886	CcSEcCtD
Nortriptyline—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000883	CcSEcCtD
Nortriptyline—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000288	0.00088	CcSEcCtD
Nortriptyline—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000287	0.000878	CcSEcCtD
Nortriptyline—DRD2—cerebellum—peripheral nervous system neoplasm	0.000287	0.00741	CbGeAlD
Nortriptyline—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000877	CcSEcCtD
Nortriptyline—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000872	CcSEcCtD
Nortriptyline—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000285	0.000869	CcSEcCtD
Nortriptyline—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000284	0.000866	CcSEcCtD
Nortriptyline—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000281	0.00086	CcSEcCtD
Nortriptyline—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000281	0.000859	CcSEcCtD
Nortriptyline—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000281	0.000857	CcSEcCtD
Nortriptyline—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000279	0.000852	CcSEcCtD
Nortriptyline—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000278	0.00085	CcSEcCtD
Nortriptyline—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000847	CcSEcCtD
Nortriptyline—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000276	0.000844	CcSEcCtD
Nortriptyline—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000276	0.000843	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000843	CcSEcCtD
Nortriptyline—Clomipramine—ABCB1—peripheral nervous system neoplasm	0.000276	0.0405	CrCbGaD
Nortriptyline—Chlorprothixene—ABCB1—peripheral nervous system neoplasm	0.000274	0.0403	CrCbGaD
Nortriptyline—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000838	CcSEcCtD
Nortriptyline—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000838	CcSEcCtD
Nortriptyline—Constipation—Etoposide—peripheral nervous system neoplasm	0.000274	0.000836	CcSEcCtD
Nortriptyline—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000271	0.000828	CcSEcCtD
Nortriptyline—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00027	0.000826	CcSEcCtD
Nortriptyline—Sweating—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000824	CcSEcCtD
Nortriptyline—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000824	CcSEcCtD
Nortriptyline—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000812	CcSEcCtD
Nortriptyline—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000807	CcSEcCtD
Nortriptyline—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000264	0.000806	CcSEcCtD
Nortriptyline—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000263	0.000803	CcSEcCtD
Nortriptyline—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000802	CcSEcCtD
Nortriptyline—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000261	0.000798	CcSEcCtD
Nortriptyline—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000261	0.000797	CcSEcCtD
Nortriptyline—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000795	CcSEcCtD
Nortriptyline—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000259	0.00079	CcSEcCtD
Nortriptyline—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000258	0.000789	CcSEcCtD
Nortriptyline—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000257	0.000786	CcSEcCtD
Nortriptyline—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000257	0.000785	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.00078	CcSEcCtD
Nortriptyline—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000254	0.000777	CcSEcCtD
Nortriptyline—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000775	CcSEcCtD
Nortriptyline—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000775	CcSEcCtD
Nortriptyline—Trimipramine—ABCB1—peripheral nervous system neoplasm	0.000254	0.0373	CrCbGaD
Nortriptyline—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000253	0.000773	CcSEcCtD
Nortriptyline—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000253	0.000773	CcSEcCtD
Nortriptyline—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000772	CcSEcCtD
Nortriptyline—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000768	CcSEcCtD
Nortriptyline—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000251	0.000768	CcSEcCtD
Nortriptyline—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000251	0.000766	CcSEcCtD
Nortriptyline—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000762	CcSEcCtD
Nortriptyline—Rash—Vincristine—peripheral nervous system neoplasm	0.000249	0.000761	CcSEcCtD
Nortriptyline—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000249	0.00076	CcSEcCtD
Nortriptyline—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000249	0.00076	CcSEcCtD
Nortriptyline—Headache—Vincristine—peripheral nervous system neoplasm	0.000248	0.000756	CcSEcCtD
Nortriptyline—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000244	0.000744	CcSEcCtD
Nortriptyline—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000742	CcSEcCtD
Nortriptyline—Doxepin—ABCB1—peripheral nervous system neoplasm	0.000242	0.0355	CrCbGaD
Nortriptyline—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000239	0.00073	CcSEcCtD
Nortriptyline—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000721	CcSEcCtD
Nortriptyline—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000236	0.000721	CcSEcCtD
Nortriptyline—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000719	CcSEcCtD
Nortriptyline—Nausea—Vincristine—peripheral nervous system neoplasm	0.000235	0.000717	CcSEcCtD
Nortriptyline—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000716	CcSEcCtD
Nortriptyline—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000714	CcSEcCtD
Nortriptyline—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.00071	CcSEcCtD
Nortriptyline—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000703	CcSEcCtD
Nortriptyline—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00023	0.000702	CcSEcCtD
Nortriptyline—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000226	0.000692	CcSEcCtD
Nortriptyline—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000689	CcSEcCtD
Nortriptyline—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000682	CcSEcCtD
Nortriptyline—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000222	0.000679	CcSEcCtD
Nortriptyline—Desipramine—ABCB1—peripheral nervous system neoplasm	0.000222	0.0326	CrCbGaD
Nortriptyline—Rash—Cisplatin—peripheral nervous system neoplasm	0.00022	0.000673	CcSEcCtD
Nortriptyline—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00022	0.000672	CcSEcCtD
Nortriptyline—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000219	0.000669	CcSEcCtD
Nortriptyline—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000667	CcSEcCtD
Nortriptyline—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.000218	0.00562	CbGeAlD
Nortriptyline—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000666	CcSEcCtD
Nortriptyline—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000663	CcSEcCtD
Nortriptyline—Tension—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000659	CcSEcCtD
Nortriptyline—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000658	CcSEcCtD
Nortriptyline—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000652	CcSEcCtD
Nortriptyline—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000212	0.000647	CcSEcCtD
Nortriptyline—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000638	CcSEcCtD
Nortriptyline—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000208	0.000634	CcSEcCtD
Nortriptyline—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000633	CcSEcCtD
Nortriptyline—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000631	CcSEcCtD
Nortriptyline—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000623	CcSEcCtD
Nortriptyline—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000204	0.000622	CcSEcCtD
Nortriptyline—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000617	CcSEcCtD
Nortriptyline—Rash—Etoposide—peripheral nervous system neoplasm	0.000202	0.000617	CcSEcCtD
Nortriptyline—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000202	0.000616	CcSEcCtD
Nortriptyline—Headache—Etoposide—peripheral nervous system neoplasm	0.000201	0.000613	CcSEcCtD
Nortriptyline—Tension—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.00061	CcSEcCtD
Nortriptyline—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000609	CcSEcCtD
Nortriptyline—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000606	CcSEcCtD
Nortriptyline—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000604	CcSEcCtD
Nortriptyline—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000602	CcSEcCtD
Nortriptyline—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000601	CcSEcCtD
Nortriptyline—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000594	CcSEcCtD
Nortriptyline—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000193	0.00059	CcSEcCtD
Nortriptyline—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000586	CcSEcCtD
Nortriptyline—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000582	CcSEcCtD
Nortriptyline—Nausea—Etoposide—peripheral nervous system neoplasm	0.00019	0.000581	CcSEcCtD
Nortriptyline—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00019	0.00058	CcSEcCtD
Nortriptyline—HTR2A—cerebellum—peripheral nervous system neoplasm	0.00019	0.00489	CbGeAlD
Nortriptyline—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000577	CcSEcCtD
Nortriptyline—Imipramine—ABCB1—peripheral nervous system neoplasm	0.000188	0.0276	CrCbGaD
Nortriptyline—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000571	CcSEcCtD
Nortriptyline—Amitriptyline—ABCB1—peripheral nervous system neoplasm	0.000187	0.0275	CrCbGaD
Nortriptyline—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000187	0.00057	CcSEcCtD
Nortriptyline—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000565	CcSEcCtD
Nortriptyline—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.00056	CcSEcCtD
Nortriptyline—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000559	CcSEcCtD
Nortriptyline—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000557	CcSEcCtD
Nortriptyline—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000556	CcSEcCtD
Nortriptyline—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000553	CcSEcCtD
Nortriptyline—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000549	CcSEcCtD
Nortriptyline—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000548	CcSEcCtD
Nortriptyline—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000546	CcSEcCtD
Nortriptyline—Shock—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000539	CcSEcCtD
Nortriptyline—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000538	CcSEcCtD
Nortriptyline—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000537	CcSEcCtD
Nortriptyline—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000537	CcSEcCtD
Nortriptyline—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000535	CcSEcCtD
Nortriptyline—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000173	0.00053	CcSEcCtD
Nortriptyline—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000173	0.00445	CbGeAlD
Nortriptyline—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000527	CcSEcCtD
Nortriptyline—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000523	CcSEcCtD
Nortriptyline—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000523	CcSEcCtD
Nortriptyline—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000517	CcSEcCtD
Nortriptyline—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000512	CcSEcCtD
Nortriptyline—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000511	CcSEcCtD
Nortriptyline—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000507	CcSEcCtD
Nortriptyline—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000499	CcSEcCtD
Nortriptyline—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000497	CcSEcCtD
Nortriptyline—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000496	CcSEcCtD
Nortriptyline—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000495	CcSEcCtD
Nortriptyline—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000492	CcSEcCtD
Nortriptyline—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.00049	CcSEcCtD
Nortriptyline—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000487	CcSEcCtD
Nortriptyline—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000484	CcSEcCtD
Nortriptyline—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000483	CcSEcCtD
Nortriptyline—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000477	CcSEcCtD
Nortriptyline—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000474	CcSEcCtD
Nortriptyline—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000473	CcSEcCtD
Nortriptyline—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000469	CcSEcCtD
Nortriptyline—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000459	CcSEcCtD
Nortriptyline—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000455	CcSEcCtD
Nortriptyline—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000452	CcSEcCtD
Nortriptyline—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000451	CcSEcCtD
Nortriptyline—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000446	CcSEcCtD
Nortriptyline—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000441	CcSEcCtD
Nortriptyline—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000437	CcSEcCtD
Nortriptyline—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000435	CcSEcCtD
Nortriptyline—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000434	CcSEcCtD
Nortriptyline—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000433	CcSEcCtD
Nortriptyline—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000433	CcSEcCtD
Nortriptyline—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000418	CcSEcCtD
Nortriptyline—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000404	CcSEcCtD
Nortriptyline—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000403	CcSEcCtD
Nortriptyline—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000401	CcSEcCtD
Nortriptyline—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000401	CcSEcCtD
Nortriptyline—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000393	CcSEcCtD
Nortriptyline—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000388	CcSEcCtD
Nortriptyline—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000375	CcSEcCtD
Nortriptyline—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000374	CcSEcCtD
Nortriptyline—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000364	CcSEcCtD
Nortriptyline—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000363	CcSEcCtD
Nortriptyline—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000359	CcSEcCtD
Nortriptyline—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000349	CcSEcCtD
Nortriptyline—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000347	CcSEcCtD
Nortriptyline—Rash—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000346	CcSEcCtD
Nortriptyline—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000345	CcSEcCtD
Nortriptyline—Headache—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000343	CcSEcCtD
Nortriptyline—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000335	CcSEcCtD
Nortriptyline—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000326	CcSEcCtD
Nortriptyline—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000323	CcSEcCtD
Nortriptyline—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.00032	CcSEcCtD
Nortriptyline—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.00032	CcSEcCtD
Nortriptyline—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000318	CcSEcCtD
Nortriptyline—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.86e-05	0.000301	CcSEcCtD
Nortriptyline—CHRM3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.67e-05	0.000268	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.67e-05	0.000268	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.66e-05	0.000267	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.66e-05	0.000266	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.65e-05	0.000265	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.65e-05	0.000265	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.64e-05	0.000264	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.64e-05	0.000263	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.63e-05	0.000262	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.63e-05	0.000261	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.62e-05	0.000261	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.61e-05	0.000259	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.6e-05	0.000258	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	1.6e-05	0.000258	CbGpPWpGaD
Nortriptyline—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.59e-05	0.000256	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.59e-05	0.000255	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.59e-05	0.000255	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.58e-05	0.000254	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.57e-05	0.000252	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.56e-05	0.000251	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.56e-05	0.000251	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.56e-05	0.000251	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.56e-05	0.00025	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.55e-05	0.00025	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	1.55e-05	0.00025	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.55e-05	0.000249	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.53e-05	0.000247	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.53e-05	0.000246	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.53e-05	0.000246	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—TH—peripheral nervous system neoplasm	1.51e-05	0.000242	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.5e-05	0.00024	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.47e-05	0.000236	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.46e-05	0.000234	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	1.44e-05	0.000231	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.43e-05	0.00023	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.43e-05	0.00023	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	1.43e-05	0.00023	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.43e-05	0.00023	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	1.43e-05	0.00023	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.43e-05	0.000229	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.42e-05	0.000228	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.41e-05	0.000226	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.41e-05	0.000226	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.41e-05	0.000226	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.4e-05	0.000226	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	1.4e-05	0.000225	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.37e-05	0.000221	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	1.35e-05	0.000218	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.35e-05	0.000216	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.33e-05	0.000213	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.32e-05	0.000213	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.32e-05	0.000213	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	1.31e-05	0.000211	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	1.27e-05	0.000204	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.26e-05	0.000203	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.25e-05	0.000201	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.24e-05	0.0002	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	1.23e-05	0.000198	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.23e-05	0.000198	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	1.23e-05	0.000198	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	1.21e-05	0.000194	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.17e-05	0.000189	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.17e-05	0.000188	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.16e-05	0.000187	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.16e-05	0.000186	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.15e-05	0.000185	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.15e-05	0.000184	CbGpPWpGaD
Nortriptyline—HTR6—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.13e-05	0.000181	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.12e-05	0.00018	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.12e-05	0.00018	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.12e-05	0.00018	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.11e-05	0.000179	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	1.1e-05	0.000178	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.1e-05	0.000177	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.09e-05	0.000176	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	1.08e-05	0.000174	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.07e-05	0.000172	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.06e-05	0.000171	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	1.05e-05	0.00017	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.05e-05	0.000169	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.05e-05	0.000168	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.05e-05	0.000168	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.03e-05	0.000166	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.02e-05	0.000165	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.02e-05	0.000165	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.02e-05	0.000164	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.02e-05	0.000163	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.01e-05	0.000163	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.01e-05	0.000163	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.01e-05	0.000163	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.01e-05	0.000162	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.01e-05	0.000162	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	1.01e-05	0.000162	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.01e-05	0.000162	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	9.97e-06	0.00016	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.96e-06	0.00016	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.95e-06	0.00016	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.94e-06	0.00016	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.93e-06	0.00016	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.91e-06	0.000159	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	9.89e-06	0.000159	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.88e-06	0.000159	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.85e-06	0.000158	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.78e-06	0.000157	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.75e-06	0.000157	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	9.7e-06	0.000156	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.66e-06	0.000155	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.58e-06	0.000154	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.49e-06	0.000153	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.37e-06	0.000151	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	9.28e-06	0.000149	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.25e-06	0.000149	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.11e-06	0.000147	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.07e-06	0.000146	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.83e-06	0.000142	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.72e-06	0.00014	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.7e-06	0.00014	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.68e-06	0.00014	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	8.66e-06	0.000139	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	8.61e-06	0.000138	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.59e-06	0.000138	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.54e-06	0.000137	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.46e-06	0.000136	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	8.45e-06	0.000136	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.35e-06	0.000134	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.3e-06	0.000134	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.27e-06	0.000133	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.26e-06	0.000133	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.23e-06	0.000132	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.23e-06	0.000132	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	8.19e-06	0.000132	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.18e-06	0.000131	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	8.14e-06	0.000131	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8e-06	0.000129	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.95e-06	0.000128	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.95e-06	0.000128	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.88e-06	0.000127	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.88e-06	0.000127	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.87e-06	0.000127	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.86e-06	0.000126	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.83e-06	0.000126	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.81e-06	0.000125	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.73e-06	0.000124	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.71e-06	0.000124	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.58e-06	0.000122	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.54e-06	0.000121	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.54e-06	0.000121	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.42e-06	0.000119	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.41e-06	0.000119	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.4e-06	0.000119	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.38e-06	0.000119	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.35e-06	0.000118	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.33e-06	0.000118	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.28e-06	0.000117	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.26e-06	0.000117	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.26e-06	0.000117	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.22e-06	0.000116	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.21e-06	0.000116	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.2e-06	0.000116	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.17e-06	0.000115	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.16e-06	0.000115	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.15e-06	0.000115	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.15e-06	0.000115	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.13e-06	0.000115	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.11e-06	0.000114	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.08e-06	0.000114	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.08e-06	0.000114	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.06e-06	0.000114	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.02e-06	0.000113	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7e-06	0.000112	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.93e-06	0.000111	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.9e-06	0.000111	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.85e-06	0.00011	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.76e-06	0.000109	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.66e-06	0.000107	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	6.64e-06	0.000107	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.6e-06	0.000106	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.55e-06	0.000105	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.53e-06	0.000105	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	6.52e-06	0.000105	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.51e-06	0.000105	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.49e-06	0.000104	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.47e-06	0.000104	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.46e-06	0.000104	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.46e-06	0.000104	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.43e-06	0.000103	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.42e-06	0.000103	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.41e-06	0.000103	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.19e-06	9.95e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.15e-06	9.89e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.09e-06	9.79e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.08e-06	9.78e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.05e-06	9.73e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.99e-06	9.63e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.98e-06	9.61e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.96e-06	9.58e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.94e-06	9.55e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.88e-06	9.45e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.86e-06	9.43e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.82e-06	9.36e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.71e-06	9.18e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.67e-06	9.12e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.58e-06	8.97e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.57e-06	8.95e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.55e-06	8.92e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.53e-06	8.89e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.48e-06	8.81e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.47e-06	8.79e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.46e-06	8.78e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.3e-06	8.53e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.28e-06	8.48e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	5.17e-06	8.32e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.14e-06	8.26e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.07e-06	8.15e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.05e-06	8.12e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.05e-06	8.11e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.83e-06	7.77e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.66e-06	7.49e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	4.59e-06	7.38e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.58e-06	7.37e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.57e-06	7.35e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.56e-06	7.33e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.54e-06	7.3e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.5e-06	7.23e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.49e-06	7.21e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.48e-06	7.2e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.46e-06	7.16e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.45e-06	7.16e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.38e-06	7.04e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.37e-06	7.03e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.36e-06	7.01e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.34e-06	6.98e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.3e-06	6.92e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.29e-06	6.9e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.26e-06	6.86e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.93e-06	6.32e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.87e-06	6.22e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	3.87e-06	6.21e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.86e-06	6.21e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	3.86e-06	6.2e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.85e-06	6.19e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.84e-06	6.17e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.8e-06	6.11e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.79e-06	6.09e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	3.32e-06	5.34e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	2.98e-06	4.79e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	2.74e-06	4.41e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	2.72e-06	4.37e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.32e-06	3.74e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.79e-06	2.88e-05	CbGpPWpGaD
